Hydrochlorothiazide Capsule, Gelatin Coated
Product Images NDC 42708-027

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 42708-027). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

42708 027 30

Label for Hydrochlorothiazide Capsules USP, 12.5 mg, containing 30 gelatin-coated capsules. The label notes the product is a sample, not for sale, and advises dosage per package insert. Distributed by QPharma, Inc., Cedar Knolls, NJ. It instructs to keep the container tightly closed and out of reach of children, with storage at controlled room temperature. The label includes spaces for prescription dosing directions and is marked Rx Only.*

FDA Label Image

Hydrochlorothiazide Capsules, Usp, 12.5 mg Is The 3,4-dihydro Derivative Of Chlorothiazide. Its Chemical Name Is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide. Its Empirical Formula Is C7h8cln3o4s2; Its Molecular Weight Is 297.74; And Its Structural Formula Is: (Hydrochlorothiazide Capsule 01)

Chemical structure of Hydrochlorothiazide showing a benzothiadiazine ring with sulfonamide groups, an amine, and a chlorine atom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.